Algorithm-based individualization methodology of the starting gonadotropin dose in IVF/ICSI and the freeze-all strategy prevent OHSS equally in normal responders: a systematic review and network meta-analysis of the evidence.
Algorithm-based individualization of starting gonadotropin dose
Freeze-all policy
Normal responders
Journal
Journal of assisted reproduction and genetics
ISSN: 1573-7330
Titre abrégé: J Assist Reprod Genet
Pays: Netherlands
ID NLM: 9206495
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
received:
03
01
2022
accepted:
21
04
2022
pubmed:
14
5
2022
medline:
13
8
2022
entrez:
13
5
2022
Statut:
ppublish
Résumé
Ovarian hyperstimulation syndrome (OHSS) represents a rare but dangerous condition associated with controlled ovarian stimulation (COS) in IVF/ICSI. Over the last decades, many strategies have been introduced into clinical practice with the objective of preventing this potentially life-threatening condition. Among these, the freeze-all policy has gained great popularity, thanks to improvements in vitrification. Nevertheless, not all clinics have adequate skills in vitrification procedures and patients may be dissatisfied with a longer time to pregnancy. This study is a systematic review and network meta-analysis of randomized controlled trials comparing different strategies of ovarian stimulation in IVF/ICSI cycles (freeze-all policy, algorithm-based individualization of the starting dose, experience-based individualization of the starting dose, standard dose) in terms of reduction of OHSS, in normal responders. The results indicate that only the algorithm-based individualization of the starting gonadotropin dose reduces OHSS similarly to the freeze-all strategy. Albeit in the era of the freeze-all policy, the personalization of the starting gonadotropin dose obtained by the use of algorithms should be pursued as a valid and safe option for IVF.
Identifiants
pubmed: 35551563
doi: 10.1007/s10815-022-02503-2
pii: 10.1007/s10815-022-02503-2
pmc: PMC9365921
doi:
Substances chimiques
Gonadotropins
0
Gonadotropin-Releasing Hormone
33515-09-2
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1583-1601Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
N Engl J Med. 2018 Jan 11;378(2):126-136
pubmed: 29320646
J Clin Epidemiol. 2006 Sep;59(9):881-6
pubmed: 16895808
Reprod Biomed Online. 2019 Feb;38(2):195-205
pubmed: 30594482
Hum Reprod. 2017 Dec 01;32(12):2485-2495
pubmed: 29121350
Fertil Steril. 2018 Sep;110(4):661-670.e1
pubmed: 30196963
Panminerva Med. 2019 Mar;61(1):42-51
pubmed: 30674181
Fertil Steril. 2017 Feb;107(2):387-396.e4
pubmed: 27912901
Reprod Biomed Online. 2017 Apr;34(4):429-438
pubmed: 28189417
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Cochrane Database Syst Rev. 2018 Feb 01;2:CD012693
pubmed: 29388198
Hum Reprod Open. 2019 Feb 27;2019(1):hoz003
pubmed: 30895268
Clin Exp Reprod Med. 2021 Jun;48(2):163-173
pubmed: 34024083
Hum Reprod. 2015 Jun;30(6):1473-80
pubmed: 25883033
BMJ. 2020 Aug 5;370:m2519
pubmed: 32759285
N Engl J Med. 2018 Jan 11;378(2):137-147
pubmed: 29320655
Hum Reprod. 2003 Nov;18(11):2275-82
pubmed: 14585873
Front Endocrinol (Lausanne). 2021 Sep 14;12:688654
pubmed: 34594300
Hum Reprod Open. 2021 Aug 05;2021(3):hoab026
pubmed: 34377841
BMJ. 2015 Jan 02;350:g7647
pubmed: 25555855
BMC Med Res Methodol. 2013 Mar 09;13:35
pubmed: 23496991
Res Synth Methods. 2016 Sep;7(3):236-63
pubmed: 26754852
Fertil Steril. 2018 May;109(5):768-774
pubmed: 29778369
Hum Reprod. 2020 Jul 1;35(7):1675-1684
pubmed: 32575120
Hum Reprod. 2018 Jan 1;33(1):58-64
pubmed: 29136154
Reprod Biomed Online. 2014 Nov;29(5):541-4
pubmed: 25246114
Ann Intern Med. 2015 Jun 2;162(11):777-84
pubmed: 26030634
Fertil Steril. 2014 Apr;101(4):1008-11
pubmed: 24534283
Cochrane Database Syst Rev. 2017 Jan 23;1:CD012103
pubmed: 28111738
Fertil Steril. 2008 Jul;90(1):186-93
pubmed: 17980870
Hum Reprod. 2011 Jul;26(7):1768-74
pubmed: 21558332
Front Endocrinol (Lausanne). 2019 Apr 26;10:181
pubmed: 31080437
Reprod Biomed Online. 2015 Mar;30(3):248-57
pubmed: 25596910
Reprod Biomed Online. 2021 May;42(5):909-918
pubmed: 33722477
Hum Reprod Open. 2020 May 01;2020(2):hoaa009
pubmed: 32395637
Res Synth Methods. 2012 Jun;3(2):98-110
pubmed: 26062084
Lancet. 2019 Mar 30;393(10178):1310-1318
pubmed: 30827784
Reprod Biol Endocrinol. 2020 Feb 22;18(1):14
pubmed: 32087702
Hum Reprod Update. 2019 Jan 1;25(1):2-14
pubmed: 30388233
Hum Reprod. 2019 Mar 1;34(3):491-505
pubmed: 30689865
Hum Reprod. 2021 Aug 18;36(9):2452-2462
pubmed: 34179971
Cochrane Database Syst Rev. 2021 Feb 4;2:CD011184
pubmed: 33539543
Fertil Steril. 2015 Apr;103(4):931-938.e2
pubmed: 25638421